Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
Frequently asked questions
What sector does Peptron Inc (087010) operate in?
Peptron Inc belongs to the Healthcare sector and operates in the Biotechnology & Medical Research industry.
What is Peptron Inc (087010) current stock price?
As of the latest data, Peptron Inc stock price is ₩196,700, with a previous close of ₩196,700.
What is Peptron Inc (087010) current market capitalization?
Peptron Inc market cap is approximately 3.01 trillion.
Does Peptron Inc (087010) pay dividends?
No. Peptron Inc does not pay a dividend.
What is Peptron Inc (087010) beta (volatility) score?
Peptron Inc has a beta of 0.741, indicating lower volatility than the overall market.
